NEUROKININ-INDUCED CHANGES IN PIAL ARTERY DIAMETER IN THE ANESTHETIZED GUINEA-PIG

被引:24
作者
BEATTIE, DT
STUBBS, CM
CONNOR, HE
FENIUK, W
机构
[1] Department of Neuropharmacology, Glaxo Group Research Ltd, Ware, Hertfordshire, SG12 0DP, Park Road
关键词
PIAL ARTERY; VASODILATATION; SUBSTANCE-P; NEUROKININ RECEPTORS; CALCITONIN GENE-RELATED PEPTIDE (CGRP); GR73632; GR64349; GR82334;
D O I
10.1111/j.1476-5381.1993.tb13454.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of selective neurokinin agents on pial artery diameter, measured with an on-line image analyser, have been studied in anaesthetized guinea-pigs in order to characterize the neurokinin receptors present on pial arteries. 2 Perivascular injection of either substance P (0.01-1 muM) or the selective NK1 receptor agonists, substance P methyl ester (SPOMe, 0.01-1 muM) and GR73632 (0.1 muM), increased pial artery diameter. 3 In contrast, the selective NK2 receptor agonist, GR64349 (1 muM), produced a small vasoconstriction while the NK3 receptor-selective agonist, senktide (1 muM) was inactive. 4 Co-administration of GR82334 (1 muM), a selective NK1 receptor antagonist, inhibited the vasodilatation produced by SPOMe (0.1 muM) but not that caused by calcitonin gene-related peptide (CGRP, 0.01 muM). 5 The results are consistent with an involvement of NK1 receptors in the neurokinin-induced increase in guinea-pig pial artery diameter.
引用
收藏
页码:146 / 149
页数:4
相关论文
共 25 条
  • [1] CALCITONIN GENE-RELATED PEPTIDE IS A POTENT VASODILATOR
    BRAIN, SD
    WILLIAMS, TJ
    TIPPINS, JR
    MORRIS, HR
    MACINTYRE, I
    [J]. NATURE, 1985, 313 (5997) : 54 - 56
  • [2] DIFFERENT RECEPTORS ARE INVOLVED IN THE ENDOTHELIUM-MEDIATED RELAXATION AND THE SMOOTH-MUSCLE CONTRACTION OF THE RABBIT PULMONARY-ARTERY IN RESPONSE TO SUBSTANCE-P AND RELATED NEUROKININS
    DORLEANSJUSTE, P
    DION, S
    DRAPEAU, G
    REGOLI, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 125 (01) : 37 - 44
  • [3] EDVINSSON L, 1981, J PHYSIOL-LONDON, V318, P251
  • [4] EDVINSSON L, 1983, CELL TISSUE RES, V234, P1
  • [5] RELEASE OF VASOACTIVE PEPTIDES IN THE EXTRACEREBRAL CIRCULATION OF HUMANS AND THE CAT DURING ACTIVATION OF THE TRIGEMINOVASCULAR SYSTEM
    GOADSBY, PJ
    EDVINSSON, L
    EKMAN, R
    [J]. ANNALS OF NEUROLOGY, 1988, 23 (02) : 193 - 196
  • [6] TACHYKININ RECEPTOR TYPES - CLASSIFICATION AND MEMBRANE SIGNALING MECHANISMS
    GUARD, S
    WATSON, SP
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1991, 18 (02) : 149 - 165
  • [7] RECEPTOR-SELECTIVE, PEPTIDASE-RESISTANT AGONISTS AT NEUROKININ NK-1 AND NK-2 RECEPTORS - NEW TOOLS FOR INVESTIGATING NEUROKININ FUNCTION
    HAGAN, RM
    IRELAND, SJ
    JORDAN, CC
    BERESFORD, IJM
    DEAL, MJ
    WARD, P
    [J]. NEUROPEPTIDES, 1991, 19 (02) : 127 - 135
  • [8] HAGAN RM, 1991, BRIT J PHARMACOL, V102, pP168
  • [9] MODE OF ACTION OF THE ANTIMIGRAINE DRUG SUMATRIPTAN
    HUMPHREY, PPA
    FENIUK, W
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (12) : 444 - 446
  • [10] RECEPTORS MEDIATING TACHYKININ-INDUCED CONTRACTILE RESPONSES IN GUINEA-PIG TRACHEA
    IRELAND, SJ
    BAILEY, F
    COOK, A
    HAGAN, RM
    JORDAN, CC
    STEPHENSSMITH, ML
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1463 - 1469